Effect of the Olive Leaf Tea Ingestion in Post-prandial Glycemic Response (OLIFTEA)
NCT ID: NCT05397509
Last Updated: 2022-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2022-04-29
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
Allocation of the first beverage to each participant is made by randomization.
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Olive Leaf Tea
Olive Leaf Tea
Olive leaf tea
250 mL of Olive leaf tea and a high-glycemic breakfast
Placebo tea
Placebo tea
Placebo tea
250 mL of placebo tea and a high-glycemic breakfast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Olive leaf tea
250 mL of Olive leaf tea and a high-glycemic breakfast
Placebo tea
250 mL of placebo tea and a high-glycemic breakfast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Politécnico de Bragança
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manuela Meireles
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuela Meireles, PhD
Role: PRINCIPAL_INVESTIGATOR
Instituto Politécnico de Bragança
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
escola Superior de Saúde
Bragança, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Manuela Meireles, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
361221
Identifier Type: -
Identifier Source: org_study_id